Drug
Cyb704
Cyb704: highest development phase Phase 3, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| CYB704 NCT06847724 | Phase 3 | Relapsing Multiple Sclerosis |
Latest
No recent events.
Follow Cyb704 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.